[
    [
        {
            "time": "2019-09-19",
            "original_text": "【提前看】19日公告精选：深交所公开谴责*ST新海及相关当事人；复星医药控股股东拟增持不低于1亿元股份",
            "features": {
                "keywords": [
                    "*ST新海",
                    "复星医药",
                    "增持",
                    "深交所",
                    "公开谴责"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【提前看】19日公告精选：深交所公开谴责*ST新海及相关当事人；复星医药控股股东拟增持不低于1亿元股份",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-09-19",
            "original_text": "19日晚公告精选｜*ST大控或被终止上市；又一家公司成为华为合格供应商 风险提示",
            "features": {
                "keywords": [
                    "*ST大控",
                    "终止上市",
                    "华为",
                    "合格供应商"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "19日晚公告精选｜*ST大控或被终止上市；又一家公司成为华为合格供应商 风险提示",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-09-20",
            "original_text": "武汉凡谷控股股东及一致人减持1%",
            "features": {
                "keywords": [
                    "武汉凡谷",
                    "减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "通信设备"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "武汉凡谷控股股东及一致人减持1%",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-09-25",
            "original_text": "复宏汉霖将挂牌，港交所风吹依旧",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "挂牌",
                    "港交所"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复宏汉霖将挂牌，港交所风吹依旧",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-09-25",
            "original_text": "复宏汉霖发售价为49.6港元，拟于9月25日上市；整合营销供应商艾德韦宣赴港IPO；唯医骨科完成亿元B轮融资",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "IPO",
                    "艾德韦宣",
                    "唯医骨科"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "营销服务",
                    "医疗科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复宏汉霖发售价为49.6港元，拟于9月25日上市；整合营销供应商艾德韦宣赴港IPO；唯医骨科完成亿元B轮融资",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]